Option Care Health Strategy and Business Model

Executive Overview

Option Care Health is a U.S. provider of home and alternate-site infusion therapy, specialty pharmacy services, and related clinical support. In its current form, the company was created in 2019 through the merger of BioScrip and Option Care Enterprises, and it is headquartered in Bannockburn, Illinois. The company operates in the post-acute and specialty-care part of healthcare, where the core value proposition is to move appropriate infusion treatment out of higher-cost hospital settings and into the home or ambulatory infusion suites while maintaining clinical oversight, pharmacy services, reimbursement support, and nursing care.

What makes Option Care Health strategically important is not just drug dispensing. It manages a complex care-delivery model that combines specialty-drug procurement, sterile compounding, benefit verification, prior authorization, clinical monitoring, nursing coordination, and collections from multiple payer types. That creates value for payers seeking lower site-of-care costs, for hospitals seeking discharge capacity, for physicians looking for a reliable infusion partner, and for patients who want treatment outside the hospital. For 2023, Option Care Health reported approximately $4.3 billion in revenue. Its footprint is overwhelmingly U.S.-focused, with a national network of pharmacies, ambulatory infusion suites, and nursing capabilities supporting both acute and chronic infusion therapies.

Option Care Health at a Glance

Logo
Common name	Option Care Health
Full legal name	Option Care Health, Inc.
Headquarters	Bannockburn, Illinois, United States
Ownership	Public company; broadly held institutional ownership
Ticker	OPCH
Exchange	NASDAQ
Market Cap	$3.45B
Revenue (FY2024)	#N/A
Founding / major historical milestones	Current company formed in 2019 through the merger of BioScrip and Option Care Enterprises; subsequent growth has included de novo expansion and tuck-in acquisitions.
Industry or industries	Home infusion, alternate-site infusion, specialty pharmacy, post-acute healthcare services
Key products or services	Home infusion therapy, ambulatory infusion suite services, specialty pharmacy distribution, nursing services, clinical monitoring, reimbursement support
Geographic footprint	United States; national operating footprint with pharmacies, infusion suites, and nursing coverage
Business segments as officially reported	One reportable segment
Company website	https://optioncarehealth.com/

1. What Is the Strategy of Option Care Health?

Option Care Health’s public disclosures consistently describe a strategy built around expanding access to infusion therapy in lower-cost care settings, broadening clinical capabilities, and using national scale to serve payers, referral sources, pharmaceutical manufacturers, and patients. Framed through the Playing to Win lens, the company’s strategy is relatively clear.

1a. What is the winning aspiration of Option Care Health?

Option Care Health’s winning aspiration is to be a preferred national platform for infusion care outside the hospital. In practical terms, winning means being the provider that health plans, physicians, hospital systems, and patients trust to deliver complex infusion therapies safely at home or in ambulatory infusion suites at a lower total cost than hospital outpatient departments. Public commentary also suggests that management wants to compound growth through a mix of organic expansion, new therapy access, and disciplined acquisitions rather than simply defend a mature infusion base. The company has emphasized growth in revenue, adjusted earnings, and cash generation, but it has not centered public strategy around a single long-term market-share target.
1b. Where does Option Care Health play?

Option Care Health plays in U.S. home and alternate-site infusion, not in broad retail pharmacy or inpatient acute-care delivery. It focuses on therapies that require infusion-related clinical services, pharmacy handling, benefit coordination, and ongoing patient monitoring. Its field of play includes patients transitioning from hospitals, patients with chronic conditions requiring recurring infusions, physician-directed biologic therapy, and specialty therapies where payer economics favor lower-cost sites of care. It also plays where pharmaceutical manufacturers value a clinically capable distribution and patient-support channel, particularly for specialty and limited-distribution products.
1c. How does Option Care Health plan to win?

Option Care Health appears to plan to win through a mix of cost-of-care advantage and operational reliability. The company is not a pure low-price provider; instead, it offers a lower-cost setting relative to hospital outpatient infusion while still managing clinical complexity. Its differentiation rests on national scale, broad therapy expertise, payer access, pharmacy capabilities, nursing coordination, and the ability to serve patients across home and ambulatory settings. That combination can make it attractive both to payers seeking savings and to referral sources seeking dependable patient transitions. The company has also pursued growth by adding new geographies and capabilities through tuck-in acquisitions and branch expansion.
1d. What capabilities must Option Care Health have in place?

To execute this strategy, Option Care Health needs strong capabilities in specialty-drug procurement, sterile compounding, cold-chain handling, clinical pharmacy, nursing coordination, payer contracting, reimbursement and prior authorization, referral conversion, and revenue-cycle management. It also needs the ability to secure access to important therapies, integrate acquisitions, and maintain quality and accreditation standards across a distributed operating footprint. In this industry, operational execution is a core strategic capability because a clinically strong but administratively weak provider can still lose on reimbursement, collections, or patient onboarding speed.
1e. What management systems does Option Care Health require?

Option Care Health requires management systems that tightly link clinical quality, compliance, operating efficiency, and reimbursement performance. That includes pharmacy and nursing protocols, utilization and scheduling systems, drug inventory controls, site-of-care economics, payer-contract analytics, referral-tracking tools, and collection discipline. Because the company operates in a regulated healthcare environment, management systems around accreditation, patient safety, controlled documentation, and audit readiness are especially important. Just as important are capital-allocation systems that decide where to open or acquire sites, which therapies to prioritize, and how much infrastructure to build ahead of demand.

2. What Are the Current Strategic Initiatives of Option Care Health?

Expand care in lower-cost alternate sites

Option Care Health has continued to invest in moving infusion care out of hospital outpatient departments and into the home or ambulatory infusion suites where clinically appropriate. This is a central strategic theme because payers benefit from lower total cost, hospitals free up capacity, and patients often gain convenience.
Increase exposure to chronic and specialty therapies

Management has emphasized therapy categories with recurring utilization and higher clinical complexity. Inference from public disclosures suggests that chronic therapies, immunoglobulin-related treatments, biologics, and rare-disease categories matter because they are more repeat-driven than one-time acute episodes and can support stronger patient retention and better branch economics.
Deepen payer and referral-source relationships

Option Care Health’s strategy depends on payer-network participation and referral conversion. Public commentary has highlighted the importance of close alignment with commercial payers, government programs, hospital systems, discharge planners, and physician specialists so that eligible patients are directed into the company’s care model quickly and compliantly.
Add capacity through de novos and tuck-in acquisitions

The company has used selective acquisitions and local expansion to broaden coverage, add therapy capability, and improve density in attractive markets. This remains important in a fragmented industry where local presence affects referral capture, clinician recruiting, and route efficiency.
Improve operational execution in reimbursement-heavy workflows

Benefit verification, prior authorization, collections, and denial management are critical in home infusion. Option Care Health has continued to focus on operating discipline in these functions because growth without strong revenue-cycle execution can dilute cash flow and margins.
Capture demand created by industry dislocation

Industry disruption, including the retrenchment of some competitors in home infusion, has created referral and hiring opportunities. Management has discussed market-share opportunities from this disruption, but the real strategic challenge is converting those opportunities without overloading onboarding, supply, or clinical capacity.

3. What Is the Business Model of Option Care Health?

Option Care Health’s business model combines specialty pharmaceutical distribution with clinical care delivery. Customers do not buy a simple pharmacy fill. They buy an integrated infusion episode that can include the drug, compounding, supplies, pumps, nursing visits, benefit verification, clinical monitoring, and reimbursement administration.

What customers actually buy

The economic offering is safe administration of infused therapies outside the hospital, with the provider taking on much of the complexity required to make that possible. For referral sources, the value is continuity of care after discharge or after a physician prescribes an infused therapy. For payers, the value is lower site-of-care cost. For patients, the value is convenience and care coordination.

Recurring versus one-time revenue

The model is partly recurring and partly episodic. Acute anti-infective therapy after a hospitalization can be relatively short-cycle, while immunoglobulin, nutrition support, inflammatory disease therapies, and certain rare-disease treatments can be recurring for months or years. That makes therapy mix a major driver of revenue durability.

How pricing power works

Pricing power is limited and highly mediated by payer contracts, drug reimbursement formulas, and manufacturer access. Option Care Health does not have unconstrained price-setting power in the way a consumer brand might. Instead, economics depend on the spread between drug acquisition cost and reimbursement, plus the value of the clinical service bundle and the company’s ability to keep labor and overhead efficient.

Why business mix matters

Business mix matters because chronic specialty therapies usually have different margin, working-capital, and retention characteristics than acute therapies. A provider with more recurring chronic therapy tends to have better visibility and potentially better operating leverage, while acute therapy can be more referral-driven and volume-sensitive.

What drives margins and cash generation

Gross profit is driven by therapy mix, procurement economics, reimbursement terms, and clinical service efficiency. Operating margin depends on branch density, clinician utilization, referral conversion, and overhead leverage. Cash generation depends heavily on working-capital discipline because expensive drugs are purchased before claims are collected from payers. Inventory turns, days sales outstanding, and denial management therefore matter a great deal.

Revenue model

The revenue model is best described as reimbursement-driven healthcare services rather than subscription. Payment is generally tied to drugs dispensed, infusion-related services delivered, nursing services, and other reimbursable components of care. For recurring chronic therapies, the pattern can look subscription-like from a demand standpoint, but contractually it is still episode- and claim-based.

4. What Products and Services Does Option Care Health Sell?

Option Care Health sells a combination of specialty infusion therapies and related clinical services.

Home infusion therapy: delivery of infused medications and clinical support in the patient’s home.
Ambulatory infusion suite services: infusion treatment provided in company-operated outpatient settings for patients who do not need hospital-based care but benefit from supervised administration.
Specialty pharmacy services: procurement, dispensing, benefit coordination, and therapy management for high-cost specialty medications.
Nursing and clinical monitoring: nurse visits, patient education, adherence support, adverse-event monitoring, and coordination with prescribers.
Pharmacy operations: sterile compounding, dose preparation, equipment and supplies, and medication logistics.
Reimbursement support: benefit verification, prior authorization, payer coordination, and billing support.

Therapy categories typically include anti-infective therapy, immunoglobulin therapy, nutrition support, and other complex specialty infusions. From a strategic standpoint, recurring chronic and specialty therapies appear especially important because they can create longer patient duration and better economics than short-term acute episodes. Acute anti-infective care remains important operationally, especially through hospital discharge channels, but it is not the only value driver.

5. What Are the Key Competitors or Peers of Option Care Health?

Option Care Health operates in a fragmented market, so competition comes from a mix of national providers, regional specialists, integrated healthcare companies, and substitute sites of care.

CVS Health / Coram: historically one of the most important national home infusion competitors, although CVS announced a major pullback from Coram beginning in 2023, which has reshaped the market.
Optum: through its pharmacy and care-delivery capabilities, Optum is a relevant integrated competitor in specialty drug management and infusion-related services.
Soleo Health: a private independent provider focused on specialty infusion and pharmacy services across multiple therapy categories.
KabaFusion: an independent home infusion company with national reach and meaningful presence in chronic therapies such as immunoglobulin.
Paragon Healthcare: a provider of ambulatory infusion services and specialty pharmacy capabilities, often relevant in alternate-site infusion.
CarepathRx: a health-system-oriented infusion and pharmacy-services platform that can compete for hospital partnerships and patient referrals.
Accredo / Evernorth: primarily a specialty pharmacy platform rather than a direct home infusion clone, but still a substitute in some therapies and payer-controlled channels.
Hospital outpatient infusion centers: these are major substitutes because many therapies can be administered in hospital-owned settings, albeit often at higher cost.
Physician-office infusion providers: especially relevant in rheumatology, gastroenterology, and other specialties where infused biologics are administered in-office.
Regional independent infusion providers: many local and regional operators compete on relationships, responsiveness, and clinician availability in specific markets.

The competitive dynamic is not just about price. Access to payer networks, clinical capabilities, local branch density, speed of referral intake, and manufacturer relationships can all influence who wins.

6. What Is the Marketing Strategy of Option Care Health?

Option Care Health’s marketing strategy is primarily relationship-based and clinically oriented rather than consumer-advertising driven. This is typical for a reimbursement-driven healthcare service model where the key “buyers” are often payers, referral sources, and prescribing clinicians rather than walk-in consumers.

The company’s practical marketing channels appear to include:

Referral-source marketing: education and outreach to hospital discharge planners, case managers, physicians, and health systems.
Payer-facing value communication: demonstrating cost savings and quality outcomes tied to lower-cost sites of care.
Clinical credibility: using outcomes, service reliability, accreditation, and therapy expertise as trust signals.
Local market business development: branch- and region-level outreach that supports referral conversion in specific geographies.
Manufacturer relationship development: positioning the company as a capable partner for specialty and limited-distribution therapies.

Brand marketing matters, but mostly as a supporting capability. Option Care Health does not appear to rely on mass-market brand advertising. Its marketing advantage is more likely to come from service reputation, network participation, and the ability to solve referral and reimbursement friction for clinicians and payers.

7. What Are the Key Customer Segments of Option Care Health?

Option Care Health serves several distinct customer groups, even though the patient is the end recipient of care.

Patients requiring infusion therapy: individuals with acute infections, chronic immune conditions, nutrition needs, inflammatory disorders, and other conditions requiring infused treatment.
Commercial payers and managed care organizations: these are crucial because reimbursement, network inclusion, and site-of-care policies directly influence patient flow and economics.
Government-related payers: Medicare and Medicaid programs are important parts of the reimbursement mix in infusion care.
Hospitals and health systems: they refer discharged patients and often value a reliable post-acute infusion partner.
Physician specialists and physician practices: prescribing clinicians influence therapy choice, site of care, and referral pathways.
Pharmaceutical manufacturers: while not always a direct revenue customer in the same way as a payer, manufacturers matter strategically where access to a therapy or distribution network depends on strong provider capabilities.

The business is diversified across customer types, but it is structurally dependent on large payer relationships and on continued referral flow from providers. In that sense, economic concentration is often higher than a simple patient count would imply.

8. What Is the Sales Model of Option Care Health?

Option Care Health sells through a multi-channel, relationship-driven sales model rather than through retail storefronts.

How the company goes to market

Direct referral capture: local and regional business development teams work with hospitals, discharge planners, case managers, and physician practices.
Payer contracting: the company negotiates network participation and reimbursement terms with health plans and other payers.
Manufacturer access: gaining access to specialty therapies can require direct engagement with pharmaceutical manufacturers.
Patient onboarding: once referred, patients are converted through benefit verification, authorization, care planning, and scheduling.

How channel structure affects the business

The sales model makes channel execution strategically important. If Option Care Health has strong local relationships but weak payer access, growth stalls. If it has broad payer access but slow intake, referrals can leak away to competitors. This also affects pricing and customer intimacy: close referral relationships can improve retention and mix, but payer contracts still heavily constrain economics.

For consultants, this channel structure creates clear project opportunities in referral conversion analytics, payer-segmentation strategy, local market prioritization, and end-to-end intake redesign.

9. In What Geographies Does Option Care Health Operate?

Option Care Health is primarily a United States business. Its operating footprint spans the U.S. through a network of pharmacies, ambulatory infusion suites, and field nursing capabilities rather than through meaningful international operations.

Geographic reach matters because infusion care is still delivered locally. Even a nationally branded provider needs local compounding capacity, nursing coverage, physician relationships, and route density. Option Care Health’s model therefore combines national contracting and systems with local execution in metropolitan and regional markets.

The company’s strategic geography is not just where it has branches, but where it can achieve enough density to serve patients efficiently, recruit clinicians, maintain referral relationships, and support reimbursement operations. The U.S. footprint is broad, but the economics are inherently market-by-market.

10. Who Are the Owners of Option Care Health?

Option Care Health is a publicly traded company on Nasdaq and, as of 2024, appears to be widely held by institutional investors rather than controlled by a single shareholder. Large holders reported in 2024 commonly included major asset managers such as The Vanguard Group and BlackRock, with other sizable positions held by active institutional investors. No single shareholder appears to have a controlling stake based on typical public ownership disclosures.

Because institutional ownership changes quarter to quarter, any holder list should be treated as time-sensitive.

11. How Is Option Care Health Organized?

Officially, Option Care Health reports as one reportable segment. That is important because it means investors do not get a detailed segment breakout between home infusion, ambulatory infusion, pharmacy functions, or therapy categories.

Practically, however, the company operates through a more layered structure that likely includes:

local pharmacies and infusion centers,
clinical operations covering pharmacists, nurses, and patient care coordination,
payer contracting and reimbursement functions,
sales and referral development teams,
procurement and supply-chain management, and
corporate support functions such as finance, compliance, IT, and integration.

This distinction matters. The reporting structure is simple, but the operating model is not. Option Care Health is a distributed healthcare-delivery network that requires local execution under centralized clinical, financial, and regulatory controls.

12. How Does Option Care Health Operate?

On a day-to-day basis, Option Care Health operates as a care-coordination and medication-delivery platform wrapped around infusion therapy.

Referral intake: a physician, hospital, or health system refers a patient for infusion therapy.
Coverage verification: the company verifies benefits, obtains prior authorization where needed, and determines the appropriate site of care.
Care plan setup: pharmacy, nursing, and scheduling teams coordinate drug, dosage, supplies, delivery, and monitoring.
Drug fulfillment: medications are sourced, stored, and often compounded under regulated pharmacy standards.
Administration: therapy is delivered in the patient’s home or at an ambulatory infusion suite.
Monitoring and billing: the company tracks adherence, clinical response, adverse events, documentation, and payer reimbursement.

The major operating complexities are reimbursement administration, sterile pharmacy execution, clinician scheduling, therapy-specific protocols, and working-capital management. Bottlenecks can emerge in prior authorization, nursing availability, drug supply, and collections. In this business, operational friction does not merely reduce efficiency; it can directly reduce patient conversion and revenue capture.

13. What Are the Growth Opportunities for Option Care Health?

Option Care Health’s most plausible growth opportunities are closely tied to structural shifts in U.S. healthcare delivery.

More site-of-care migration: payers continue to favor infusion outside hospital outpatient departments where clinically appropriate.
Higher specialty-drug utilization: the specialty pharmaceutical pipeline can create new infusion opportunities, especially in chronic and rare diseases.
Recurring therapy mix improvement: expanding exposure to chronic, repeat-driven therapies can improve visibility and branch economics.
Geographic density expansion: de novos and acquisitions can improve local scale in underpenetrated markets.
Health-system partnerships: hospitals need post-acute partners that can safely absorb patients and reduce inpatient length of stay.
Manufacturer access: stronger limited-distribution and specialty-therapy relationships can widen the addressable portfolio.
Operating leverage: better intake, scheduling, reimbursement, and procurement systems can expand margin even without dramatic top-line acceleration.

The main constraints are also clear: reimbursement pressure, labor availability, drug shortages, payer steerage, competition from integrated healthcare platforms, and therapy mix shifts toward self-administered products that do not require the same infusion infrastructure.

14. What Is the History of Option Care Health?

Option Care Health, in its current form, was created in 2019 when BioScrip merged with private Option Care Enterprises. That merger is the key historical event because it combined a public-company infusion platform with a larger private alternate-site infusion business and established the scale of today’s company.

Before the merger, BioScrip had already shifted toward infusion and specialty pharmacy after narrowing its business focus. The post-merger company adopted the Option Care Health name and positioned itself around home and alternate-site infusion services.

Since 2019, the company’s history has been shaped less by headline-grabbing corporate restructurings and more by steady network building: branch expansion, therapy additions, payer and referral relationship development, and selective acquisitions that add local density or clinical capability. In other words, Option Care Health’s history is mainly a story of scale formation and operating-platform refinement in a fragmented healthcare niche.

15. What Are the Key Suppliers to Option Care Health?

Suppliers are strategically important to Option Care Health because the company’s economics and service reliability depend on consistent access to high-cost specialty drugs and related medical inputs.

The most important supplier categories include:

Pharmaceutical manufacturers: especially those producing infused specialty and rare-disease therapies.
Drug wholesalers and specialty distributors: these intermediaries matter for sourcing, availability, and working-capital efficiency.
Compounding and pharmacy inputs: sterile supplies, diluents, infusion pumps, tubing, and other consumables.
Logistics and courier providers: cold-chain and time-sensitive medication delivery are essential in infusion care.
Technology and service vendors: pharmacy systems, revenue-cycle tools, and claims-related platforms support daily execution.

Supplier structure matters because limited-distribution drugs can effectively determine whether a provider participates in attractive therapy categories. In infusion, access is often as strategically important as price.

16. How Does the Supply Chain of Option Care Health Function?

Option Care Health’s supply chain is a healthcare supply chain, not a traditional industrial one, but it is still central to performance.

Core supply-chain steps

Sourcing: drugs and supplies are sourced from manufacturers and distribution partners.
Pharmacy handling: medications are stored, prepared, and, where required, compounded under strict regulatory standards.
Inventory management: the company must balance service reliability against the cost and risk of carrying expensive, time-sensitive inventory.
Distribution: drugs and supplies are shipped to homes, infusion suites, or other care settings using controlled logistics.
Administration support: supplies, pumps, and clinical coordination must align with nursing schedules and patient appointments.
Documentation and billing linkage: supply-chain execution must feed accurately into clinical records and claims submission.

Reliability and timing are critical. Delays can disrupt therapy, harm patient experience, and delay reimbursement. That makes procurement discipline, cold-chain integrity, and branch-level coordination strategically important, especially during drug shortages or rapid patient onboarding periods.

17. What Is the Talent Strategy of Option Care Health?

Talent is a major operating constraint and competitive advantage in home infusion. Option Care Health’s most critical talent pools include pharmacists, nurses, reimbursement specialists, intake staff, and local business-development personnel.

Public disclosures indicate that attracting and retaining clinicians is important to the company’s ability to grow safely. That makes talent strategy less about broad employer branding and more about practical execution: recruiting nurses in local markets, maintaining clinical training, retaining experienced reimbursement staff, and ensuring acquired teams can be integrated into common processes and standards.

In this model, labor quality influences both clinical outcomes and conversion economics. A shortage of nurses or high turnover in intake and billing can quickly become a growth bottleneck, even if demand is strong.

18. What Is the Finance Strategy of Option Care Health?

Option Care Health’s finance strategy appears centered on three priorities: preserving reimbursement discipline, funding organic and inorganic growth, and maintaining balance-sheet flexibility in a working-capital-intensive business.

The company’s financial model is shaped by expensive drug purchases and delayed cash collection from payers, so working capital is strategically important. Strong growth without strong collections can pressure cash flow. As a result, finance is closely tied to operating execution in procurement, billing, and denials management.

Capital allocation has generally supported branch expansion, acquisitions, systems investment, and clinical capacity rather than a high-payout distribution model. Inference from public disclosures suggests management favors disciplined tuck-in deals and internal expansion over highly leveraged transformational bets. For a company like Option Care Health, margin quality and cash conversion often matter as much as reported revenue growth.

19. What Major Acquisitions Has Option Care Health Made?

Acquisitions have played an important, though mostly targeted, role in Option Care Health’s development.

2019 merger with Option Care Enterprises: this was the defining transaction that created the current company and established its national scale.
Specialty Pharmacy Nursing Network (2022): a capability-oriented deal that added infusion nursing resources and supported the service model.
Infusion Ventures (2023): a geographic and capability expansion in the New England region.

The broader pattern is more important than any single deal. Option Care Health appears to use M&A mainly for local density, talent, clinical capability, and regional expansion in a fragmented market. That is different from a roll-up strategy based purely on financial engineering; the strategic logic is usually operating footprint and therapy access.

20. How Companies Like Option Care Health Leverage Independent Consultants through Umbrex

Umbrex has built a global community of more than 8,000 independent management consultants based in over 50 countries. These professionals are alumni of McKinsey, Bain, BCG, and other leading firms. Companies like Option Care Health use Umbrex when they want top-tier problem-solving capability without hiring a full consulting team and its associated overhead. Umbrex consultants support strategy, operations, organization, marketing, sales, finance, technology, ERP, and AI workstreams that are directly relevant to healthcare-services businesses built on reimbursement, local operations, and selective acquisitions.

For a company with Option Care Health’s strategy and operating model, representative Umbrex projects could include:

Site-of-care growth strategy to identify the most attractive therapies, payer segments, and markets for home and ambulatory infusion expansion.
Referral conversion redesign spanning hospital discharge channels, physician referrals, and intake operations.
Payer contract analytics to identify reimbursement leakage, denial drivers, and margin opportunities by therapy and geography.
Infusion-suite footprint optimization including de novo site selection, capacity planning, and catchment-area analysis.
Specialty-therapy access strategy focused on manufacturer relationships, limited-distribution opportunities, and therapy portfolio prioritization.
Revenue-cycle improvement work on prior authorization, documentation quality, collections, and days sales outstanding.
Nursing and pharmacist workforce strategy covering recruiting, retention, productivity, and market-by-market staffing models.
Supply-chain and procurement resilience assessment for specialty drugs, cold-chain logistics, and branch inventory policies.
Tuck-in acquisition screening, commercial diligence, and post-merger integration support for regional infusion providers.
AI and automation roadmap for referral intake, scheduling, reimbursement workflows, and management reporting.